EcoDrugPlus

Prostaglandin F Receptor

Ensembl ID : ENSCHAG00000023340
Gene Symbol: PTGFR
3 Cross references
195 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSCHAG00000007250
Gene Symbol: PTGIR
1 Cross references
188 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSCHAG00000025340
Gene Symbol: PTGS1
1 Cross references
196 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2b

Ensembl ID : ENSCHAG00000014478
Gene Symbol: PTGS2B
1 Cross references
213 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSCHAG00000025756
Gene Symbol: PSMA1
3 Cross references
271 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSCHAG00000013320
Gene Symbol: PSMA3
3 Cross references
252 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSCHAG00000027474
Gene Symbol: PSMA4
3 Cross references
199 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSCHAG00000023385
Gene Symbol: PSMA5
3 Cross references
212 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSCHAG00000005047
Gene Symbol: PSMA6
3 Cross references
241 Possible Orthologues:

Proteasome 20s Subunit Alpha 6b

Ensembl ID : ENSCHAG00000004030
Gene Symbol: PSMA6B
1 Cross references
213 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSCHAG00000023064
Gene Symbol: PSMA7
3 Cross references
158 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSCHAG00000008146
Gene Symbol: PSMA8
1 Cross references
140 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).